Tokyo, Japan, February, 5, 2021 – Teijin Limited has made the following personnel changes effective as of April 1, 2021.
New Position
Member of the Board
Executive Officer, Representative Director of the Board
Chief Financial Officer
Executive Officer, Member of the Board
Chief Social Responsibility Officer
Responsible for Corporate Audit Department
Executive Officer, Member of the Board
Chief Officer (Corporate Strategy)
Teijin Group Executive Officer
Management Coordinator for the President, Healthcare
Business of Teijin Group（for Teijin Pharma）
President, Teijin Pharma Limited
Teijin Group Executive Officer
President, Healthcare Business of Teijin Group
General Manager, Healthcare New Business Division
Teijin Group Executive Officer
President, Material Business of Teijin Group
Teijin Group Corporate Officer
General Manager, Composites Business Unit
President, Continental Structural Plastics Holdings Corporation
President, Continental Structural Plastics, Inc.
Teijin Group Corporate Officer
General Manager, Material Technology Center
Teijin Group Corporate Officer
Chief Officer (Legal, Intellectual Property)
General Manager, Intellectual Property Department
Teijin Group Corporate Officer
Chief Officer (Engineering)
Deputy Chief Social Responsibility Officer（for Disaster Prevention)
Director, Effective Utilization of Factories Project
Director, Iwakuni Factory and Matsuyama Factory
Responsible for Polyester related Residual asset management Team

Current Position
Senior Executive Officer, Representative Director of the Board
Chief Financial Officer
Executive Officer, Member of the Board
President, Healthcare Business of Teijin Group
Executive Officer, Member of the Board
President, Material Business of Teijin Group

Name
Yoshihisa Sonobe

Corporate Officer, Member of the Board
Chief Officer (Corporate Strategy)
Teijin Group Executive Officer
Management Coordinator for the President, Healthcare
Business of Teijin Group (for Teijin Pharma)
President, Teijin Pharma Limited(General Manager, Marketing and Sales Unit)
Teijin Group Corporate Officer
General Manager, Healthcare New Business Division

Eiji Ogawa

Teijin Group Corporate Officer
General Manager, Composites Business Unit
Teijin Group Corporate Officer
President, Continental Structural Plastics Holdings Corporation
President, Continental Structural Plastics, Inc.

Akimoto Uchikawa

Teijin Group Corporate Officer
Deputy General Manager, Material Technology Center（forEnvironmental Solution Development）
General Manager, Intellectual Property Department
General Manager, Project Promotion Office

Ton de Weijer

Teijin Group Chief Representative in Europe
President, Teijin Holdings Europe B.V.

Teruo Aoyagi

Akihisa Nabeshima
Toshiya Koyama

Ichiro Watanabe

Naohiko MoriyamaSteve Rooney

Akihiko Uchiyama

New Position
Teijin Group Corporate Officer
General Manager, Marketing and Sales Unit, Teijin Pharma Limited
Teijin Group Corporate Officer
Deputy Chief Financial Officer
General Manager, Accounting Department
Teijin Group Corporate Officer
Management Coordinator for the President, Material Businessof Teijin Group（for Intelligence）
Advisor for Technology
Teijin Group Chief Representative in Europe
President, Teijin Holdings Europe B.V.

Teijin Group Chief Representative in China
President, Teijin (China) Investment Co., Ltd.
Chief Representative, Teijin Limited Beijing Office
General Manager, Legal Department
General Manager, Material Business Strategic Planning andControl Division
President, Teijin Healthcare Limited
Scheduled to retire
Scheduled to retire

Scheduled to retire

Current Position
President, Teijin Healthcare Limited

Name
Masato Tanaka

General Manager, Material Business Strategic Planning andControl Division

Junji Kitahama

Assistant to Chief Social Responsibility Officer

Yutaka Horie

Teijin Group Executive Officer
Chief Officer (Legal, Intellectual Property)
General Manager, Material Technology Center
General Manager, Teijin Institute for Bio-medical Research, Teijin
Pharma Limited
General Manager, Pharmaceutical Discovery Research Laboratories
Seconded to Teijin Limited（Assistant to President, Healthcare
Business of Teijin Group）
Deputy Chief Officer (Global Business Strategy)（For Overseasbase cooperation）

Hiroyuki Umetani

Legal Department

Takeshi Kotera

General Manager, Accounting Department

Toru Yamaura

General Manager, Sales Planning and Support Division, Teijin
Pharma Limited
Teijin Group Senior Executive Officer
Chief Social Responsibility Officer
Responsible for Corporate Audit Department
Teijin Group Executive Officer
Chief Officer (Engineering)
Deputy Chief Social Responsibility Officer（for Disaster Prevention)
Director, Effective Utilization of Factories Project
Director, Iwakuni Factory and Matsuyama Factory
Responsible for Polyester related Residual asset management TeamTeijin Group Corporate Officer
Chief Representative, Teijin Limited in China
President, Teijin (China) Investment Co., Ltd.
Chief Representative, Teijin Limited Beijing Office

Yoshihisa Fujikawa

Tomohide Ida

Manabu Yamamoto

Yasuhiro Hayakawa
Taizo Makari

Takeshi Miyawaki

New Position
Scheduled to retire
Scheduled to retire

Current Position
Teijin Group Corporate Officer
General Manager, Legal Department
Advisor for TechnologyName
Nobuyuki Nishitani
Hirofumi Murooka* The appointments for the directors of Group Companies shall be effective upon the approval of general meetings of shareholders and the board ofdirectors meetings of each Company.

About the Teijin Group
Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the fields of environmental value; safety, security and disastermitigation; and demographic change and increased health consciousness. Originally established as Japan's first rayon manufacturer in 1918,
Teijin has evolved into a unique enterprise encompassing three core business domains: high-performance materials including aramid, carbon
fibers and composites, and also resin and plastic processing, films, polyester fibers and products converting; healthcare including pharmaceuticals
and home healthcare equipment for bone/joint, respiratory and cardiovascular/metabolic diseases, nursing care and pre-symptomatic healthcare;and IT including B2B solutions for medical, corporate and public systems as well as packaged software and B2C online services for digitalentertainment. Deeply committed to its stakeholders, as expressed in the brand statement “Human Chemistry, Human Solutions,” Teijin aims to
be a company that supports the society of the future. The group comprises more than 170 companies and employs some 20,000 people across
20 countries worldwide. Teijin posted consolidated sales of JPY 853.7 billion (USD 8.0 billion) and total assets of JPY 1,004.2 billion (USD 9.4billion) in the fiscal year that ended on March 31, 2020.
Please visit www.teijin.com
Press Contact
Corporate Communications
Teijin Limited+81 (0)3 3506 4055
pr@teijin.co.jp